Do analysts rate RVP or XAIR?

Beyond Air has a consensus price target of $10.00, indicating a potential upside of 2,538.52%. Given Beyond Air's stronger consensus rating and higher probable upside, analysts clearly believe Beyond Air is more favorable than Retractable Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Retractable Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Beyond Air 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Which has better earnings and valuation, XAIR or LFWD?

Lifeward has higher revenue and earnings than Beyond Air. Lifeward is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Beyond Air $3.70M 1.35 -$46.62M -$5.43 N/A Lifeward $22.03M 0.91 -$19.91M -$19.66 N/A

Is XAIR or LFWD more profitable?

Lifeward has a net margin of -123.66% compared to Beyond Air's net margin of -447.75%. Lifeward's return on equity of -243.14% beat Beyond Air's return on equity. Company Net Margins Return on Equity Return on Assets Beyond Air -447.75% -268.82% -98.49% Lifeward -123.66% -243.14% -97.39%

Does the media refer more to XAIR or LFWD?

In the previous week, Beyond Air had 2 more articles in the media than Lifeward. MarketBeat recorded 4 mentions for Beyond Air and 2 mentions for Lifeward. Lifeward's average media sentiment score of 1.33 beat Beyond Air's score of 1.16 indicating that Lifeward is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Beyond Air 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Lifeward 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation & earnings, XAIR or IRIX?

IRIDEX has higher revenue and earnings than Beyond Air. IRIDEX is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Beyond Air $3.70M 1.35 -$46.62M -$5.43 N/A IRIDEX $52.67M 0.38 -$4.44M -$0.19 N/A

Is XAIR or IRIX more profitable?

IRIDEX has a net margin of -6.23% compared to Beyond Air's net margin of -447.75%. Beyond Air's return on equity of -268.82% beat IRIDEX's return on equity. Company Net Margins Return on Equity Return on Assets Beyond Air -447.75% -268.82% -98.49% IRIDEX -6.23% -1,204.74% -11.16%

Does the media favor XAIR or IRIX?

In the previous week, Beyond Air had 1 more articles in the media than IRIDEX. MarketBeat recorded 4 mentions for Beyond Air and 3 mentions for IRIDEX. Beyond Air's average media sentiment score of 1.16 beat IRIDEX's score of 0.87 indicating that Beyond Air is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Beyond Air 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive IRIDEX 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend XAIR or TMDIF?

Beyond Air currently has a consensus price target of $10.00, indicating a potential upside of 2,538.52%. Given Beyond Air's stronger consensus rating and higher possible upside, analysts clearly believe Beyond Air is more favorable than Titan Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Beyond Air 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Titan Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is XAIR or TMDIF more profitable?

Titan Medical has a net margin of 0.00% compared to Beyond Air's net margin of -447.75%. Titan Medical's return on equity of -82.31% beat Beyond Air's return on equity. Company Net Margins Return on Equity Return on Assets Beyond Air -447.75% -268.82% -98.49% Titan Medical N/A -82.31% -51.47%

Is XAIR or CODX more profitable?

Beyond Air has a net margin of -447.75% compared to Co-Diagnostics' net margin of -6,760.63%. Co-Diagnostics' return on equity of -164.92% beat Beyond Air's return on equity. Company Net Margins Return on Equity Return on Assets Beyond Air -447.75% -268.82% -98.49% Co-Diagnostics -6,760.63% -164.92% -141.15%

Does the media favor XAIR or CODX?

In the previous week, Beyond Air had 1 more articles in the media than Co-Diagnostics. MarketBeat recorded 4 mentions for Beyond Air and 3 mentions for Co-Diagnostics. Beyond Air's average media sentiment score of 1.16 beat Co-Diagnostics' score of 0.30 indicating that Beyond Air is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Beyond Air 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Co-Diagnostics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Beyond Air (XAIR) Competitors

$0.38 +0.01 (+2.16%)

As of 10:05 AM Eastern

Compare

XAIR vs. RVP, LFWD, IRIX, TMDIF, and CODX

Should you buy Beyond Air stock or one of its competitors? MarketBeat compares Beyond Air with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Beyond Air include Retractable Technologies (RVP), Lifeward (LFWD), IRIDEX (IRIX), Titan Medical (TMDIF), and Co-Diagnostics (CODX). These companies are all part of the "medical equipment" industry.

How does Beyond Air compare to Retractable Technologies?

Retractable Technologies (NYSE:RVP) and Beyond Air (NASDAQ:XAIR) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, media sentiment, risk, earnings and valuation.

7.6% of Retractable Technologies shares are held by institutional investors. Comparatively, 31.5% of Beyond Air shares are held by institutional investors. 59.5% of Retractable Technologies shares are held by insiders. Comparatively, 10.0% of Beyond Air shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Beyond Air had 4 more articles in the media than Retractable Technologies. MarketBeat recorded 4 mentions for Beyond Air and 0 mentions for Retractable Technologies. Beyond Air's average media sentiment score of 1.16 beat Retractable Technologies' score of 0.00 indicating that Beyond Air is being referred to more favorably in the news media.

Company	Overall Sentiment
Retractable Technologies	Neutral
Beyond Air	Positive

Retractable Technologies has a beta of 1.27, meaning that its stock price is 27% more volatile than the broader market. Comparatively, Beyond Air has a beta of 0.27, meaning that its stock price is 73% less volatile than the broader market.

Beyond Air has a consensus price target of $10.00, indicating a potential upside of 2,538.52%. Given Beyond Air's stronger consensus rating and higher probable upside, analysts clearly believe Beyond Air is more favorable than Retractable Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Retractable Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Retractable Technologies has a net margin of -41.11% compared to Beyond Air's net margin of -447.75%. Retractable Technologies' return on equity of -17.15% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Retractable Technologies	-41.11%	-17.15%	-9.33%
Beyond Air	-447.75%	-268.82%	-98.49%

Retractable Technologies has higher revenue and earnings than Beyond Air. Retractable Technologies is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Retractable Technologies	$37.15M	0.56	-$7.01M	-$0.21	N/A
Beyond Air	$3.70M	1.35	-$46.62M	-$5.43	N/A

Summary

Retractable Technologies and Beyond Air tied by winning 8 of the 16 factors compared between the two stocks.

How does Beyond Air compare to Lifeward?

Beyond Air (NASDAQ:XAIR) and Lifeward (NASDAQ:LFWD) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, analyst recommendations, profitability, dividends, valuation and earnings.

Lifeward has higher revenue and earnings than Beyond Air. Lifeward is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beyond Air	$3.70M	1.35	-$46.62M	-$5.43	N/A
Lifeward	$22.03M	0.91	-$19.91M	-$19.66	N/A

Beyond Air currently has a consensus price target of $10.00, indicating a potential upside of 2,538.52%. Lifeward has a consensus price target of $10.00, indicating a potential upside of 40.27%. Given Beyond Air's stronger consensus rating and higher possible upside, research analysts plainly believe Beyond Air is more favorable than Lifeward.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Lifeward	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.67

In the previous week, Beyond Air had 2 more articles in the media than Lifeward. MarketBeat recorded 4 mentions for Beyond Air and 2 mentions for Lifeward. Lifeward's average media sentiment score of 1.33 beat Beyond Air's score of 1.16 indicating that Lifeward is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Beyond Air	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Lifeward	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Beyond Air has a beta of 0.27, indicating that its stock price is 73% less volatile than the broader market. Comparatively, Lifeward has a beta of 0.36, indicating that its stock price is 64% less volatile than the broader market.

Lifeward has a net margin of -123.66% compared to Beyond Air's net margin of -447.75%. Lifeward's return on equity of -243.14% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beyond Air	-447.75%	-268.82%	-98.49%
Lifeward	-123.66%	-243.14%	-97.39%

31.5% of Beyond Air shares are held by institutional investors. Comparatively, 26.8% of Lifeward shares are held by institutional investors. 10.0% of Beyond Air shares are held by company insiders. Comparatively, 1.5% of Lifeward shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Beyond Air beats Lifeward on 9 of the 16 factors compared between the two stocks.

How does Beyond Air compare to IRIDEX?

Beyond Air (NASDAQ:XAIR) and IRIDEX (NASDAQ:IRIX) are both small-cap medical equipment companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, media sentiment, analyst recommendations, risk, dividends and valuation.

In the previous week, Beyond Air had 1 more articles in the media than IRIDEX. MarketBeat recorded 4 mentions for Beyond Air and 3 mentions for IRIDEX. Beyond Air's average media sentiment score of 1.16 beat IRIDEX's score of 0.87 indicating that Beyond Air is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Beyond Air	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
IRIDEX	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

31.5% of Beyond Air shares are owned by institutional investors. Comparatively, 20.1% of IRIDEX shares are owned by institutional investors. 10.0% of Beyond Air shares are owned by insiders. Comparatively, 8.6% of IRIDEX shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

IRIDEX has a net margin of -6.23% compared to Beyond Air's net margin of -447.75%. Beyond Air's return on equity of -268.82% beat IRIDEX's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beyond Air	-447.75%	-268.82%	-98.49%
IRIDEX	-6.23%	-1,204.74%	-11.16%

IRIDEX has higher revenue and earnings than Beyond Air. IRIDEX is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beyond Air	$3.70M	1.35	-$46.62M	-$5.43	N/A
IRIDEX	$52.67M	0.38	-$4.44M	-$0.19	N/A

Beyond Air presently has a consensus target price of $10.00, indicating a potential upside of 2,538.52%. IRIDEX has a consensus target price of $3.00, indicating a potential upside of 164.08%. Given Beyond Air's stronger consensus rating and higher probable upside, research analysts plainly believe Beyond Air is more favorable than IRIDEX.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Beyond Air has a beta of 0.27, suggesting that its share price is 73% less volatile than the broader market. Comparatively, IRIDEX has a beta of 0.64, suggesting that its share price is 36% less volatile than the broader market.

Summary

Beyond Air beats IRIDEX on 10 of the 16 factors compared between the two stocks.

How does Beyond Air compare to Titan Medical?

Beyond Air (NASDAQ:XAIR) and Titan Medical (NASDAQ:TMDIF) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, media sentiment, institutional ownership, risk, profitability, analyst recommendations and dividends.

Beyond Air currently has a consensus price target of $10.00, indicating a potential upside of 2,538.52%. Given Beyond Air's stronger consensus rating and higher possible upside, analysts clearly believe Beyond Air is more favorable than Titan Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Titan Medical has higher revenue and earnings than Beyond Air. Beyond Air is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beyond Air	$3.70M	1.35	-$46.62M	-$5.43	N/A
Titan Medical	$17.63M	1.10	$6.95M	$0.05	3.40

In the previous week, Beyond Air had 4 more articles in the media than Titan Medical. MarketBeat recorded 4 mentions for Beyond Air and 0 mentions for Titan Medical. Beyond Air's average media sentiment score of 1.16 beat Titan Medical's score of 0.00 indicating that Beyond Air is being referred to more favorably in the media.

Company	Overall Sentiment
Beyond Air	Positive
Titan Medical	Neutral

31.5% of Beyond Air shares are owned by institutional investors. Comparatively, 0.0% of Titan Medical shares are owned by institutional investors. 10.0% of Beyond Air shares are owned by insiders. Comparatively, 0.0% of Titan Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Beyond Air has a beta of 0.27, meaning that its share price is 73% less volatile than the broader market. Comparatively, Titan Medical has a beta of 1.26, meaning that its share price is 26% more volatile than the broader market.

Titan Medical has a net margin of 0.00% compared to Beyond Air's net margin of -447.75%. Titan Medical's return on equity of -82.31% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beyond Air	-447.75%	-268.82%	-98.49%
Titan Medical	N/A	-82.31%	-51.47%

Summary

Beyond Air beats Titan Medical on 9 of the 16 factors compared between the two stocks.

How does Beyond Air compare to Co-Diagnostics?

Beyond Air (NASDAQ:XAIR) and Co-Diagnostics (NASDAQ:CODX) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, valuation, media sentiment, analyst recommendations, risk, institutional ownership and dividends.

31.5% of Beyond Air shares are owned by institutional investors. Comparatively, 15.0% of Co-Diagnostics shares are owned by institutional investors. 10.0% of Beyond Air shares are owned by company insiders. Comparatively, 5.4% of Co-Diagnostics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Beyond Air presently has a consensus price target of $10.00, suggesting a potential upside of 2,538.52%. Co-Diagnostics has a consensus price target of $67.50, suggesting a potential upside of 1,565.02%. Given Beyond Air's stronger consensus rating and higher probable upside, equities analysts plainly believe Beyond Air is more favorable than Co-Diagnostics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Co-Diagnostics	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Beyond Air has a beta of 0.27, suggesting that its share price is 73% less volatile than the broader market. Comparatively, Co-Diagnostics has a beta of 2.7, suggesting that its share price is 170% more volatile than the broader market.

Beyond Air has a net margin of -447.75% compared to Co-Diagnostics' net margin of -6,760.63%. Co-Diagnostics' return on equity of -164.92% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beyond Air	-447.75%	-268.82%	-98.49%
Co-Diagnostics	-6,760.63%	-164.92%	-141.15%

Beyond Air has higher revenue and earnings than Co-Diagnostics. Co-Diagnostics is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beyond Air	$3.70M	1.35	-$46.62M	-$5.43	N/A
Co-Diagnostics	$620K	24.13	-$46.90M	-$15.77	N/A

In the previous week, Beyond Air had 1 more articles in the media than Co-Diagnostics. MarketBeat recorded 4 mentions for Beyond Air and 3 mentions for Co-Diagnostics. Beyond Air's average media sentiment score of 1.16 beat Co-Diagnostics' score of 0.30 indicating that Beyond Air is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Beyond Air	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Co-Diagnostics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Beyond Air beats Co-Diagnostics on 13 of the 16 factors compared between the two stocks.

Get Beyond Air News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding XAIR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

XAIR vs. The Competition

Export

Metric	Beyond Air	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$4.96M	$3.39B	$6.49B	$12.31B
Dividend Yield	N/A	2.25%	2.67%	5.66%
P/E Ratio	-0.07	20.05	24.05	24.76
Price / Sales	1.35	325.48	542.61	168.32
Price / Cash	N/A	53.61	27.48	37.92
Price / Book	0.11	8.16	10.69	6.90
Net Income	-$46.62M	$23.89M	$3.57B	$337.45M
7 Day Performance	-7.58%	3.66%	1.56%	2.84%
1 Month Performance	-23.88%	1.69%	2.49%	4.78%
1 Year Performance	-89.35%	46.95%	26.51%	33.08%

Beyond Air Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
XAIR Beyond Air	3.1619 of 5 stars	$0.38 +2.2%	$10.00 +2,538.5%	-89.6%	$4.96M	$3.70M	N/A	70	Positive News
RVP Retractable Technologies	N/A	$0.69 +0.2%	N/A	+7.5%	$20.60M	$37.15M	N/A	240
LFWD Lifeward	3.0805 of 5 stars	$6.98 flat	$10.00 +43.3%	-48.6%	$19.65M	$22.03M	N/A	60	Positive News Gap Up
IRIX IRIDEX	2.3977 of 5 stars	$1.12 +0.9%	$3.00 +167.9%	+19.1%	$19.32M	$52.67M	N/A	120
TMDIF Titan Medical	N/A	$0.17 -3.8%	N/A	-34.3%	$19.19M	$17.63M	N/A	50	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:XAIR) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Beyond Air (XAIR) Competitors

XAIR vs. RVP, LFWD, IRIX, TMDIF, and CODX

How does Beyond Air compare to Retractable Technologies?

Summary

How does Beyond Air compare to Lifeward?

Summary

How does Beyond Air compare to IRIDEX?

Summary

How does Beyond Air compare to Titan Medical?

Summary

How does Beyond Air compare to Co-Diagnostics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

XAIR vs. The Competition

Beyond Air Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Beyond Air (XAIR) Competitors

XAIR vs. RVP, LFWD, IRIX, TMDIF, and CODX

How does Beyond Air compare to Retractable Technologies?

Do institutionals and insiders believe in RVP or XAIR?

Does the media prefer RVP or XAIR?

Which has more risk & volatility, RVP or XAIR?

Do analysts rate RVP or XAIR?

Is RVP or XAIR more profitable?

Which has better valuation and earnings, RVP or XAIR?

Summary

How does Beyond Air compare to Lifeward?

Which has better earnings and valuation, XAIR or LFWD?

Do analysts rate XAIR or LFWD?

Does the media refer more to XAIR or LFWD?

Which has more volatility and risk, XAIR or LFWD?

Is XAIR or LFWD more profitable?

Do institutionals & insiders have more ownership in XAIR or LFWD?

Summary

How does Beyond Air compare to IRIDEX?

Does the media favor XAIR or IRIX?

Do institutionals and insiders believe in XAIR or IRIX?

Is XAIR or IRIX more profitable?

Which has better valuation & earnings, XAIR or IRIX?

Do analysts prefer XAIR or IRIX?

Which has more risk and volatility, XAIR or IRIX?

Summary

How does Beyond Air compare to Titan Medical?

Do analysts recommend XAIR or TMDIF?

Which has higher valuation & earnings, XAIR or TMDIF?

Does the media favor XAIR or TMDIF?

Do insiders & institutionals believe in XAIR or TMDIF?

Which has more volatility and risk, XAIR or TMDIF?

Is XAIR or TMDIF more profitable?

Summary

How does Beyond Air compare to Co-Diagnostics?

Do institutionals and insiders have more ownership in XAIR or CODX?

Do analysts rate XAIR or CODX?

Which has more volatility & risk, XAIR or CODX?

Is XAIR or CODX more profitable?

Which has stronger valuation and earnings, XAIR or CODX?

Does the media favor XAIR or CODX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

XAIR vs. The Competition

Beyond Air Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools